Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto.

Despite being one of the earliest Toll-like receptor (TLR)-based cancer immunotherapeutics discovered and investigated, the full extent of lipopolysaccharide (LPS) potentials within this arena remains hitherto unexploited. In this review, we will debate the challenges that have complicated the improvement of LPS-based immunotherapeutic approaches in cancer therapy. Based on their nature, those will be discussed with a focus on side effect-related, tolerance-related and in vivo model-related challenges. We will then explore how drug delivery strategies can be integrated within this domain to address such challenges in order to improve the therapeutic outcome, and will present a summary of the studies that have been dedicated thereto. This paper may inspire further developments based on reconciling the advantages of drug delivery and LPS-based cancer immunotherapy.

• Publication year

  2019

• Venue

  Therapeutic delivery

• Publication date

  2019-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.4155/tde-2018-0076PMID 30909855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.

  2019cited by this paper
• Rapidly separable microneedle patch for the sustained release of a contraceptive

  2019cited by this paper
• Design of Hollow Hyaluronic Acid Cylinders for Sustained Intravitreal Protein Delivery.

  2018cited by this paper
• Implantable drug delivery systems: An overview

  2018cited by this paper
• Whatever happened to the Shwartzman phenomenon?

  2018cited by this paper
• TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings.

  2018cited by this paper
• A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

  2018cited by this paper
• Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery

  2018cited by this paper
• Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin

  2017cited by this paper
• Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant‐dual delivery system (VADDS)

  2017cited by this paper
• Lipopolysaccharide-coated CuS nanoparticles promoted anti-cancer and anti-metastatic effect by immuno-photothermal therapy

  2017cited by this paper
• Injectable nanoparticles/hydrogels composite as sustained release system with stromal cell-derived factor-1α for calvarial bone regeneration.

  2017cited by this paper
• Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

  2016cited by this paper
• Immune Sensing of Lipopolysaccharide in Plants and Animals: Same but Different

  2016cited by this paper
• Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein

  2016cited by this paper
• Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants

  2016cited by this paper
• Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor

  2016cited by this paper
• Plasminogen activator inhibitor-1 stimulates macrophage activation through Toll-like Receptor-4.

  2016cited by this paper
• Erratum: Cancer nanomedicine: is targeting our target?

  2016cited by this paper
• Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats

  2015cited by this paper
• Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain.

  2015cited by this paper
• Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.

  2015cited by this paper
• Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells

  2015cited by this paper
• Principles of nanoparticle design for overcoming biological barriers to drug delivery

  2015cited by this paper
• Gold nanoparticle mediated cancer immunotherapy.

  2014cited by this paper
• Usefulness of oral administration of lipopolysaccharide for disease prevention through the induction of priming in macrophages.

  2014cited by this paper
• Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.

  2014cited by this paper
• Intracellular Delivery of Lipopolysaccharide Induces Effective Th1-Immune Responses Independent of IL-12

  2013cited by this paper
• Systemic inflammatory response syndrome (SIRS)

  2013cited by this paper
• Liposomal Lipopolysaccharide Initiates TRIF-Dependent Signaling Pathway Independent of CD14

  2013cited by this paper
• The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants

  2013cited by this paper
• Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine

  2013cited by this paper
• Recognition of lipopolysaccharide pattern by TLR4 complexes

  2013cited by this paper
• Negative regulatory approaches to the attenuation of Toll-like receptor signaling

  2013cited by this paper
• Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule

  2013cited by this paper
• Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model.

  2013cited by this paper
• Stimulus-responsive nanopreparations for tumor targeting.

  2013cited by this paper
• Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.

  2013cited by this paper
• Genomic responses in mouse models poorly mimic human inflammatory diseases

  2013cited by this paper
• Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

  2013cited by this paper
• Microneedle patches for vaccine delivery

  2013cited by this paper
• Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

  2012cited by this paper
• Reservoir-Based Polymer Drug Delivery Systems

  2012cited by this paper
• Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity.

  2012cited by this paper
• Targeting Dendritic Cells in vivo for Cancer Therapy

  2012cited by this paper
• Trial watch

  2012cited by this paper
• Fabrication of Silk Microneedles for Controlled‐Release Drug Delivery

  2012cited by this paper
• Controlled delivery of nanosuspensions from osmotic pumps: zero order and non-zero order kinetics.

  2012cited by this paper
• Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery

  2012cited by this paper
• Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes

  2012cited by this paper
• Origins of tumor-associated macrophages and neutrophils

  2012cited by this paper
• Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.

  2012cited by this paper
• Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins

  2012cited by this paper
• Similarities and differences of innate immune responses elicited by smooth and rough LPS.

  2012cited by this paper
• Molecular Mechanism Responsible for the Priming of Macrophage Activation*

  2012cited by this paper
• Conjugation of LPS-derived oligosaccharides to proteins using oxime chemistry.

  2011cited by this paper
• Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

  2011cited by this paper
• Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear

  2011cited by this paper
• Implantable drug delivery systems: An overview

  2011cited by this paper
• Progress in understanding adjuvant immunotoxicity mechanisms.

  2011cited by this paper
• Innate immunity and cancer therapy.

  2011cited by this paper
• Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling.

  2011cited by this paper
• Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK‐M, SHIP‐1, and A20

  2011cited by this paper
• Murine responses to endotoxin: another dirty little secret?

  2010cited by this paper
• Cytokines in the systemic inflammatory response syndrome: a review

  2010cited by this paper
• Resilience to bacterial infection: difference between species could be due to proteins in serum.

  2010cited by this paper
• Bioneedles as alternative delivery system for hepatitis B vaccine.

  2010cited by this paper
• The role of intestinal endotoxin in liver injury: A long and evolving history

  2010cited by this paper
• The role of intestinal endotoxin in liver injury: A long and evolving history

  2010cited by this paper
• Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

  2009cited by this paper
• Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

  2009cited by this paper
• Sustained release of antibiotic from polyurethane coated implant materials

  2009cited by this paper
• Endotoxin tolerance dysregulates MyD88‐ and Toll/IL‐1R domain‐containing adapter inducing IFN‐β‐dependent pathways and increases expression of negative regulators of TLR signaling

  2009cited by this paper
• Development of endotoxin tolerance in humans in vivo

  2009cited by this paper
• Hydrogel nanoparticles in drug delivery.

  2008cited by this paper
• Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel

  2008cited by this paper
• An efficient method for conjugation of a lipopolysaccharide from Salmonella enterica sv. Minnesota with probes bearing hydrazine or amino functional groups.

  2008cited by this paper
• β2-Integrin-induced p38 MAPK Activation Is a Key Mediator in the CD14/TLR4/MD2-dependent Uptake of Lipopolysaccharide by Hepatocytes*

  2008cited by this paper
• Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy.

  2008cited by this paper
• Clearance of bacterial lipopolysaccharides and lipid A by the liver and the role of arginino-succinate synthase

  2008cited by this paper
• Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system

  2008cited by this paper
• Injectable hydrogels as unique biomedical materials.

  2008cited by this paper
• Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model

  2007cited by this paper
• Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.

  2007cited by this paper
• Gene-specific control of inflammation by TLR-induced chromatin modifications

  2007cited by this paper
• Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?

  2007cited by this paper
• A rapid, small-scale procedure for the structural characterization of lipid A applied to Citrobacter and Bordetella strains: discovery of a new structural element Published, JLR Papers in Press, August 16, 2007.

  2007cited by this paper
• Methods of endotoxin removal from biological preparations: a review.

  2007cited by this paper
• Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects

  2007cited by this paper
• Exploiting EPR in polymer drug conjugate delivery for tumor targeting.

  2006cited by this paper
• Targeting dendritic cells with biomaterials: developing the next generation of vaccines.

  2006cited by this paper
• Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis

  2006cited by this paper
• HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan

  2006cited by this paper
• Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease

  2006cited by this paper
• R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells

  2006cited by this paper
• Acute Inflammatory Response to Endotoxin in Mice and Humans

  2005cited by this paper
• LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

  2004cited by this paper
• Phase-I study of intravenous modified lipid A

  2004cited by this paper
• Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.

  2004cited by this paper
• Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages.

  2004cited by this paper

• Anti-tumor Efficacy of Liposomes Encapsulating Levamisole and Lipopolysaccharide in 1, 2-Dimethylhydrazine (DMH)-Induced Colon Cancer

  2025cites this paper
• Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy.

  2025cites this paper
• Influences of calorie restriction and lipopolysaccharide therapy on inflammation, cytokine response, and cell proliferation in pancreatic adenocarcinoma mouse model

  2022cites this paper
• A Potential Mechanism of Kidney-Tonifying Herbs Treating Unexplained Recurrent Spontaneous Abortion: Clinical Evidence From the Homogeneity of Embryo Implantation and Tumor Invasion

  2022cites this paper
• Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles.

  2022cites this paper
• Bioactive Lipids and Their Derivatives in Biomedical Applications

  2021cites this paper
• Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics

  2021cites this paper
• Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing.

  2021cites this paper
• The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers

  2021cites this paper
• Role of lipopolysaccharides in potential applications of nanocarrier systems.

  2021cites this paper
• Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi’s Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin

  2020cites this paper
• Pseudomonas aeruginosa Stimulates Inflammation and Enhances KSHV-Induced Cell Proliferation and Cellular Transformation through Both LPS and Flagellin

  2020cites this paper
• Modulation of nanostructure-based LPS active immunotherapy in cancer: Size and composition determine short- and long-term tolerability.

  2019cites this paper